Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response
Open Access
- 16 October 2016
- journal article
- review article
- Published by Hindawi Limited in Stem Cells International
- Vol. 2016, 1-10
- https://doi.org/10.1155/2016/3924858
Abstract
Mesenchymal stem cells (MSCs) have attracted the attention of researchers and clinicians for their ability to differentiate into a number of cell types, participate in tissue regeneration, and repair the damaged tissues by producing various growth factors and cytokines, as well as their unique immunoprivilege in alloreactive hosts. The immunomodulatory functions of exogenous MSCs have been widely investigated in immune-mediated inflammatory diseases and transplantation research. However, a harsh environment at the site of tissue injury/inflammation with insufficient oxygen supply, abundance of reactive oxygen species, and presence of other harmful molecules that damage the adoptively transferred cells collectively lead to low survival and engraftment of the transferred cells. Preconditioning of MSCsex vivoby hypoxia, inflammatory stimulus, or other factors/conditions prior to their use in therapy is an adaptive strategy that prepares MSCs to survive in the harsh environment and to enhance their regulatory function of the local immune responses. This review focuses on a number of approaches in preconditioning human MSCs with the goal of augmenting their capacity to regulate both innate and adaptive immune responses.Keywords
Funding Information
- Nazarbayev University
This publication has 71 references indexed in Scilit:
- 3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidneyJournal of Cellular and Molecular Medicine, 2016
- Immunotolerant Properties of Mesenchymal Stem Cells: Updated ReviewStem Cells International, 2015
- Hypoxia-induced secretion of IL-10 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphomaTumor Biology, 2015
- Interferon-γ and tumor necrosis factor-α promote the ability of human placenta–derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4+interleukin-10+ and CD8+interleukin-10+Treg subsetsCytotherapy, 2015
- Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological FunctionThe International Journal of Cell Cloning, 2015
- Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector functionNature Immunology, 2015
- Effects of Hypoxia on the Immunomodulatory Properties of Human Gingiva–Derived Mesenchymal Stem CellsJournal of Dental Research, 2014
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implicationsNature Immunology, 2014
- Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage DifferentiationMolecular Therapy, 2012
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005